REGN (STOCKS)
Regeneron Pharmaceuticals Inc
$805.970000
+7.980000 (+1.00%)
Prev close: $797.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Leonard S. Schleifer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $87,213.68M
- Employees
- 15,207
- P/E (TTM)
- 19.72
- P/B (TTM)
- 2.60
- Dividend Yield
- 45.61%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $15.53B |
| Benefits Costs and Expenses | $10.37B |
| Costs And Expenses | $11.69B |
| Nonoperating Income/Loss | $1.32B |
| Operating Expenses | $11.69B |
| Selling, General, and Administrative Expenses | $2.74B |
| Research and Development | $6.28B |
| Other Operating Expenses | $2.67B |
| Operating Income/Loss | $3.84B |
| Income/Loss From Continuing Operations After Tax | $4.33B |
| Income/Loss From Continuing Operations Before Tax | $5.17B |
| Income Tax Expense/Benefit | $837.30M |
| Net Income/Loss | $4.33B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $4.33B |
| Net Income/Loss Available To Common Stockholders, Basic | $4.33B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $41.91 |
| Diluted Earnings Per Share | $40.44 |
| Basic Average Shares | 206,500,000 |
| Diluted Average Shares | 213,700,000 |
| Assets | $41.73B |
| Current Assets | $18.45B |
| Inventory | $3.08B |
| Other Current Assets | $15.36B |
| Noncurrent Assets | $23.28B |
| Intangible Assets | $1.31B |
| Other Non-current Assets | $21.97B |
| Liabilities | $10.02B |
| Current Liabilities | $5.53B |
| Accounts Payable | $1.16B |
| Other Current Liabilities | $4.37B |
| Noncurrent Liabilities | $4.49B |
| Equity | $31.71B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $31.71B |
| Liabilities And Equity | $41.73B |
| Net Cash Flow From Operating Activities | $4.68B |
| Net Cash Flow From Operating Activities, Continuing | $4.68B |
| Net Cash Flow From Investing Activities | -$704.20M |
| Net Cash Flow From Investing Activities, Continuing | -$704.20M |
| Net Cash Flow From Financing Activities | -$3.52B |
| Net Cash Flow From Financing Activities, Continuing | -$3.52B |
| Exchange Gains/Losses | -$1.90M |
| Net Cash Flow | $450.40M |
| Net Cash Flow, Continuing | $452.30M |
| Comprehensive Income/Loss | $4.31B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $4.24B |
| Other Comprehensive Income/Loss | $3.58B |
| Other Comprehensive Income/Loss Attributable To Parent | -$88.30M |